Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$55.3K
14.91K shares
What this filing means
SWARTZ ROBIN plans to sell 14.91K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $55.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001959173-26-001448
Officer· Chief Operating Officer
Since Feb 2022
14.91K
Shares to sell
$55.3K
Approx. market value
6.46K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/20/2026
6.46KTotal acquired6.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2026 | Restricted Stock Vesting Compensation | 6.46K | — |
| Total | 6.46K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.88K
Market value
$13.3K
2/18/2026
—Completed
Units to sell
4.57K
Market value
$17.6K
2/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.46K
Market value
$24.3K
2/24/2026
Total
Units
14.91K
Value
$55.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 3.88K | $13.3K | — | Completed |
2/10/2026 | 4.57K | $17.6K | — | Completed |
| Planned — Approximate Date | ||||
2/24/2026 | 6.46K | $24.3K | NASDAQ | Planned |
| Total | 14.91K | $55.3K | ||